VIMRx PHARMACEUTICALS INC. ANNOUNCES THE APPOINTMENT OF F. DONALD HUDSON AS PRESIDENT AND CHIEF EXECUTIVE OFFICER.STAMFORD, Conn.--(BUSINESS WIRE)--Dec. 21, 1994--VIMRx Pharmaceuticals Inc. (Nasdaq National Market: VMRX (Common Stock), VMRXW (Warrants)) today announced the appointment of F. Donald Hudson as its President and Chief Executive Officer, replacing Mr. Claude L. Buller. Mr. Hudson, a director of VIMRx since 1989, was a co-founder and former Chief Executive Officer of TSI TSI Total Solar Irradiance (sum solar light in energy per unit of time)
TSI Trading Standards Institute (UK)
TSI Transportation Safety Institute (US DOT) Corp. (formerly Transgenic Sciences, Inc.) a co-founder and interim Chief Executive Officer of Organogenesis organogenesis /or·ga·no·gen·e·sis/ (or?gah-no-jen´e-sis) the origin and development of organs.organogenet´ic
The formation and development of the organs of living things. , Inc. and a co-founder and Executive Vice President of Integrated Genetics, Inc. (now Genzyme, Inc.)
VIMRx Pharmaceuticals Inc. is developing therapeutic products to fight the spread of viral and retroviral diseases. The in vitro antiviral properties of hypericin hy·per·i·cin
A drug, produced synthetically or as an extract of Saint John's wort, used as an antidepressant and antiviral agent.
hypericin were initially documented at the Weizmann Institute of Science The Weizmann Institute of Science (מכון ויצמן למדע) is a world-renowned institute of higher learning and research in Rehovot, Israel. in Israel. Further studies and the discovery of the antiviral properties of hypericin were made at NYU NYU New York University
NYU New York Undercover (TV show) Medical Center. VIMRx has exclusive worldwide rights to develop and commercialize hypericin and its derivatives.
CONTACT: F. Donald Hudson
President & Chief Executive Officer VIMRx Pharmaceuticals Inc. (203) 329-0811 -or- INVESTOR RELATIONS COUNSEL: Eileen Shell, (212) 836-9606 Robert Goldstein, (212) 371-8660 The Equity Group Inc.